Qilian International Holding Group Limited (QLI)
NASDAQ: QLI · IEX Real-Time Price · USD
0.800
+0.002 (0.25%)
At close: May 31, 2024, 4:00 PM
0.899
+0.099 (12.37%)
After-hours: May 31, 2024, 7:39 PM EDT
QLI Market Cap
QLI has a market cap or net worth of $28.60 million as of May 31, 2024. Its market cap has decreased by -20.11% in one year.
Market Cap
28.60M
Enterprise Value
2.63M
1-Year Change
-20.11%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since the IPO on January 12, 2021, QLI's market cap has decreased from $175.00M to $28.60M, a decrease of -83.66%. That is a compound annual growth rate of -41.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 28.60M | 0.35% |
May 30, 2024 | 28.50M | 7.14% |
May 29, 2024 | 26.60M | -4.66% |
May 28, 2024 | 27.90M | -10.00% |
May 24, 2024 | 31.00M | 31.36% |
May 23, 2024 | 23.60M | 14.01% |
May 22, 2024 | 20.70M | -19.46% |
May 21, 2024 | 25.70M | 8.90% |
May 20, 2024 | 23.60M | -3.28% |
May 17, 2024 | 24.40M | -4.69% |
May 16, 2024 | 25.60M | 3.64% |
May 15, 2024 | 24.70M | -3.52% |
May 14, 2024 | 25.60M | -6.23% |
May 13, 2024 | 27.30M | 4.60% |
May 10, 2024 | 26.10M | 10.13% |
May 9, 2024 | 23.70M | 2.16% |
May 8, 2024 | 23.20M | -6.07% |
May 7, 2024 | 24.70M | -1.20% |
May 6, 2024 | 25.00M | 3.31% |
May 3, 2024 | 24.20M | -1.63% |
May 2, 2024 | 24.60M | 6.03% |
May 1, 2024 | 23.20M | -11.45% |
Apr 30, 2024 | 26.20M | -11.19% |
Apr 29, 2024 | 29.50M | 10.07% |
Apr 26, 2024 | 26.80M | -4.96% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Spruce Biosciences | 30.50M |
ImmunoPrecise Antibodies | 29.19M |
Palatin Technologies | 29.05M |
Spectral AI | 29.02M |
Bolt Biotherapeutics | 28.85M |
NanoViricides | 28.59M |
Enlivex Therapeutics | 28.10M |
SeaStar Medical Holding | 28.01M |